In ovarian cancer cells, the PIK3CA gene that encodes type I PI3Ks P110α is frequently mutated, which is the reason for the reduced sensitivity of tumor cells to chemotherapeutic drugs [26]. This evidence concerns the gene PIK3CA and ovarian carcinoma.